×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZVRA – zevra therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZVRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/22
09:24 pm
zvra
Zevra Ties NPC Testing Push To Valuation Gap And New CFO [Yahoo! Finance]
Low
Report
Zevra Ties NPC Testing Push To Valuation Gap And New CFO [Yahoo! Finance]
3/20
05:17 pm
zvra
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/20
04:30 pm
zvra
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
3/18
06:13 am
zvra
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
Medium
Report
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
3/16
08:03 am
zvra
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
Medium
Report
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
3/16
07:41 am
zvra
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million [Yahoo! Finance]
Medium
Report
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million [Yahoo! Finance]
3/16
07:30 am
zvra
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Low
Report
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
3/11
06:13 pm
zvra
Zevra Therapeutics (ZVRA) was upgraded by Weiss Ratings from "sell (d+)" to "hold (c+)".
Low
Report
Zevra Therapeutics (ZVRA) was upgraded by Weiss Ratings from "sell (d+)" to "hold (c+)".
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:16 pm
zvra
Form 4 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
Low
Report
Form 4 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
3/19
04:15 pm
zvra
Form 3 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
Low
Report
Form 3 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
3/16
04:46 pm
zvra
Form 144 ZEVRA THERAPEUTICS, INC. Filed by: Clifton R. LaDuane
Low
Report
Form 144 ZEVRA THERAPEUTICS, INC. Filed by: Clifton R. LaDuane
3/16
07:31 am
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 12
Low
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 12
3/9
04:28 pm
zvra
Form S-8 ZEVRA THERAPEUTICS, INC.
Medium
Report
Form S-8 ZEVRA THERAPEUTICS, INC.
3/9
04:24 pm
zvra
Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31
Low
Report
Form 10-K ZEVRA THERAPEUTICS, INC. For: Dec 31
3/9
04:06 pm
zvra
Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 04
High
Report
Form 8-K ZEVRA THERAPEUTICS, INC. For: Mar 04
2/10
04:49 pm
zvra
Form 4 ZEVRA THERAPEUTICS, INC. For: Feb 07 Filed by: McFarlane Neil F.
Low
Report
Form 4 ZEVRA THERAPEUTICS, INC. For: Feb 07 Filed by: McFarlane Neil F.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: